🔴 Nasus Pharma is trading 5.3% down in after-hours trading with no clear company-specific catalyst

Nasus Pharma is trading 5.3% down at $3.10 after the October 13 regular-session close at $3.27; no clear company-specific catalyst has been identified for the after-hours decline.

• A supplied market update attributed the regular-session decline to healthcare-sector weakness; broader indices were mixed, not sharply lower.
• Recent coverage includes earlier company announcements, but no October 13 company-specific release explaining the after-hours drop was found. Sector weakness is possible context, not a confirmed cause.